Delivery Order SPE2DB22D2206-SPE2DB24FGU37
- Not listed
- The Defense Logistics Agency awarded a $5,793.96 delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for XULTOPHY 100 Unit-3.6mg/ml Pen 3ml pharmaceutical product, with completion expected by November 7, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery...
- This federal contract award, valued at $3,892.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Mounjaro 7.5 mg/0.5 ml pens, a medication used to treat type 2 diabetes. This is a firm-fixed-price delivery order contract with a completion date of July 2, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded an...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,088.36 with a ceiling of $1,088.36. The contract is for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML, a diabetes medication, to the Defense Logistics Agency (DLA), a defense agency. The contract has an ultimate completion date of June 27, 2025 and was awarded on June 26, 2025. This contract is not set-aside and is a Firm Fixed Price agreement. Amerisourcebergen Drug...
- This federal contract award, SPE2DX22D0020|SPE2D825F24JX, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,278.12 firm fixed-price delivery order is for the supply of various pharmaceutical and medical products, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and specialty pharmaceuticals. The contract is not set aside and is part of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,451.40 to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of medications,...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $126,956.16 firm-fixed-price contract is for the supply of a range of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and represents an order under...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,181.76 firm fixed price delivery order contract is for the supply of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is not set aside and is part of a larger $999,999,999.00...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,016.26 firm-fixed-price contract is for the delivery of various pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, and pain management. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,343.00 Firm Fixed Price Delivery Order is for the supply of 4565826728 units of Insulin Lispro 100 Unit/mL Pen 3mL, with a completion date of September 17, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,581.73 firm fixed-price delivery order is for the supply of pharmaceutical and medical products, including medications across therapeutic areas such as diabetes, neurology, pain management, and antibiotics, as well as specialized medical supplies. The contract is not set aside and is part of a larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB24FGU37Delivery Order
This federal contract award is for the delivery order SPE2DB22D2206|SPE2DB24FGU37 to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $3,164.88 Firm Fixed Price contract is for the delivery of XULTOPHY 100 UNIT-3.6MG/ML PEN 3ML, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 4/22/24 |